Answers are grounded in this paper and cite their sources.
Background:The eggs of Pediculus humanus capitis are the most frequent cause of recurrence of lice infection. A few days post-drug treatment in a sub-lethal dose environment, the eggs hatch, and the nymphs are able to survive in this low-drug environment. Female lice lay eggs and cover them with a nit sheath, which is important for the viability of the eggs. The enzyme involved in nit sheath protein solidification is transglutaminase (TG).Methods:In this study, the effects of GGsTOP, an inhibitor of transglutaminase, and its silver nanoparticles (AgNPs) formulation on eggs of lice, were investigated in vitro.Results:The results showed that free GGsTOP and GGsTOP-silver nanoparticles had comparable effects on the eggs, with 20 and 10%, of hatched nymphs, respectively (p = 0.470). However, ELISA test showed that transglutaminase activity was lowest in eggs treated with GGsTOP-silver nanoparticle (1.02 ± 0.04 and 0.80 ± 0.02), relative to other groups (p = 0.0001), indicating that GGsTOP-silver nanoparticle was effective in inhibiting TG, the enzyme involved in nit sheath solidification. This result may imply that even partial inhibition of TG, such as that shown by the effect of free GGsTOP, affects egg viability.Conclusions:This study provides valuable insights into a promising novel formulation with the potential to impair louse eggs and disrupt the life cycle of infestations, especially when used at higher doses.
No takes yet. Share an insight, caveat, or question.
Alghashmari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: